BAPS collective review: chronic inflammatory bowel disease

Insights

Pediatric inflammatory bowel disease (IBD) cases, including Crohn's disease (CD) and ulcerative colitis (UC), showed significant growth issues and required surgery in over half of CD patients. Many experienced ongoing disease and complications, highlighting the chronic nature of pediatric IBD.

Area of Science:

  • Pediatric Gastroenterology
  • Inflammatory Bowel Disease Research
  • Clinical Pediatrics

Background:

  • Chronic inflammatory bowel disease (CIBD) presents unique challenges in children.
  • Early diagnosis and management are crucial for long-term outcomes in pediatric IBD.
  • Growth failure is a significant concern in pediatric Crohn's disease.

Purpose of the Study:

  • To review the clinical characteristics, diagnostic methods, and outcomes of pediatric CIBD cases.
  • To analyze the surgical management and long-term disease course in children with Crohn's disease and ulcerative colitis.
  • To assess the impact of CIBD on growth and overall health in pediatric patients.

Main Methods:

  • Retrospective review of 153 pediatric CIBD cases diagnosed between 1970-1979.
  • Analysis of diagnostic delays, presenting symptoms, and treatment interventions.
  • Evaluation of surgical outcomes, disease progression, and mortality rates at follow-up.

Main Results:

  • Mean diagnosis ages were 10.5 years for Crohn's disease (CD) and 8.8 years for ulcerative colitis (UC), with diagnostic delays of 16.3 and 9.3 months, respectively.
  • Growth failure was prominent in CD (35.7% at follow-up).
  • Surgery was required in 57% of CD cases and 26% of UC cases, with high rates of reoperation and persistent disease (65% CD, 52% UC) at mean 6-year follow-up.

Conclusions:

  • Pediatric CIBD, particularly CD, is associated with significant growth impairment and a substantial need for surgical intervention.
  • Delayed diagnosis and the chronic nature of the disease contribute to ongoing morbidity in children.
  • Effective long-term management strategies are essential for improving outcomes in pediatric IBD patients.

Related Concept Videos

Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...